# Which funds hold ElevateBio?

From the SEC Form N-PORT filings of US funds, periods ended 2026-05-31 to 2026-07-31.

Canonical page: https://tickerinside.com/private-companies/elevatebio/
Licence: CC BY 4.0, attribution to TickerInside.

On their latest SEC filings, 20 US funds held ElevateBio, worth $16.9 million in all. Fidelity Contrafund (FCNKX) held the most: $5.9 million, 0.00% of the fund, for the period ended June 30, 2026. The funds that give a share count valued one share at $1.84 to $1.84, $1.84 at the median. The first fund to report it held it in Q1 2021; 20 held it in Q2 2026.

- Funds holding it: 20
- Value held, as the funds value it: $16.9 million
- Largest holder: Fidelity Contrafund, $5.9 million
- ETFs holding it: none

## By quarter

| Quarter | Funds | Value held |
|---|---:|---:|
| Q2 2026 | 20 | $16.9M |
| Q1 2026 | 20 | $17.6M |
| Q4 2025 | 20 | $17.6M |
| Q3 2025 | 20 | $19.2M |
| Q2 2025 | 20 | $18.2M |
| Q1 2025 | 20 | $23.9M |
| Q4 2024 | 20 | $26.8M |
| Q3 2024 | 20 | $29.2M |
| Q2 2024 | 20 | $28.2M |
| Q1 2024 | 20 | $31.9M |
| Q4 2023 | 20 | $28.9M |
| Q3 2023 | 20 | $36.4M |
| Q2 2023 | 20 | $38.6M |
| Q1 2023 | 20 | $28.1M |
| Q4 2022 | 20 | $36.7M |
| Q3 2022 | 20 | $42.1M |
| Q2 2022 | 20 | $42.1M |
| Q1 2022 | 21 | $33.3M |
| Q4 2021 | 21 | $34.2M |
| Q3 2021 | 21 | $38.6M |
| Q2 2021 | 21 | $38.6M |
| Q1 2021 | 11 | $25.0M |

## Every fund holding ElevateBio

| Fund | Tickers | Value | Of the fund | Per share | Period ended | Security |
|---|---|---:|---:|---:|---|---|
| Fidelity Contrafund | FCNKX, FCNTX | $5.9M | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Growth Company Fund | FDGRX, FGCKX | $2.8M | 0.00% | $1.84 | 2026-05-31 | Series C preferred |
| Fidelity U.S. Equity Central Fund |  | $1.2M | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Advisor New Insights Fund | FINSX, FNIAX | $1.1M | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| VIP Contrafund Portfolio |  | $947,968 | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Contrafund K6 | FLCNX | $895,160 | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Series Growth Company Fund | FCGSX | $611,800 | 0.00% | $1.84 | 2026-05-31 | Series C preferred |
| Select Health Care Portfolio | FHCLX, FHCNX | $469,016 | 0.01% | $1.84 | 2026-05-31 | Series C preferred |
| Fidelity Growth Company K6 Fund | FGKFX | $455,584 | 0.00% | $1.84 | 2026-05-31 | Series C preferred |
| Select Biotechnology Portfolio | FBIOX | $398,544 | 0.01% | $1.84 | 2026-05-31 | Series C preferred |
| Select Medical Technology and Devices Portfolio | FSMEX | $395,048 | 0.01% | $1.84 | 2026-05-31 | Series C preferred |
| VIP Growth Portfolio | QVG2Q | $365,056 | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Series Opportunistic Insights Fund | FVWSX | $357,880 | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Advisor Health Care Fund | FACDX, FACTX | $300,472 | 0.01% | $1.84 | 2026-07-31 | Series C preferred |
| Fidelity Capital Appreciation Fund | FCAKX, FDCAX | $283,176 | 0.00% | $1.84 | 2026-07-31 | Series C preferred |
| Fidelity Advisor Equity Growth Fund | EPGAX, EPGCX | $204,424 | 0.00% | $1.84 | 2026-05-31 | Series C preferred |
| Fidelity Growth Discovery Fund | FDSVX, FGDKX | $139,288 | 0.00% | $1.84 | 2026-06-30 | Series C preferred |
| VIP Health Care Portfolio |  | $57,408 | 0.01% | $1.84 | 2026-06-30 | Series C preferred |
| Fidelity Advisor Series Equity Growth Fund | FMFMX | $48,392 | 0.00% | $1.84 | 2026-05-31 | Series C preferred |
| VIP Dynamic Capital Appreciation Portfolio |  | $9,752 | 0.00% | $1.84 | 2026-06-30 | Series C preferred |

## Other private companies US funds hold

- Anthropic: https://tickerinside.com/private-companies/anthropic/ (110 funds)
- Databricks: https://tickerinside.com/private-companies/databricks/ (98 funds)
- Canva: https://tickerinside.com/private-companies/canva/ (74 funds)
- Fanatics: https://tickerinside.com/private-companies/fanatics/ (21 funds)
- Lightmatter: https://tickerinside.com/private-companies/lightmatter/ (20 funds)
- Tenstorrent: https://tickerinside.com/private-companies/tenstorrent/ (20 funds)
- Kardium: https://tickerinside.com/private-companies/kardium/ (20 funds)
- Long Wall (ABL Space Systems): https://tickerinside.com/private-companies/long-wall/ (20 funds)

## Where these figures come from

A holding is a fund's common or preferred share of a company that is not listed: valued with unobservable inputs (fair value level 3) and placed privately (a restricted security, or PP in its title), never a right left from a takeover, an escrow, or a vehicle that holds such shares. A company that funds hold as a listed share in the same data set is public and left out. Rows are joined into a company by its name, its share class and legal form cut off. Each fund values its shares itself, every quarter, so two funds can value one share differently.

## Use this data

- This company: https://tickerinside.com/api/v1/private-companies/elevatebio.json
- Every company: https://tickerinside.com/api/v1/private-companies.json

## Cite this page

TickerInside, funds holding ElevateBio, from SEC Form N-PORT (2026q3 data set), https://tickerinside.com/private-companies/elevatebio/

Each value is the fund's own estimate of a share no market quotes, from its latest public SEC Form N-PORT. Measurements of public filings, not investment advice and not a way to buy a share.